These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1084731)

  • 1. [Research on V. cholerae anti-antibodies (agglutinating and vibriocidal) in patients affected by cholera-like gastroenteritis. Studies performed during the cholera epidemic occurred in Apulia in August-September 1973].
    Barbuti S; Iandolo E; Rizzo G; Leogrande G; Jatta E; Di Bari C
    Ann Sclavo; 1975; 17(3):449-59. PubMed ID: 1084731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on the efficacy of cholera vaccination in a population sample of Bari].
    Barbuti S; Iandolo E; Leogrande G; Rizzo G; Jatta E; Di Bari C
    Ann Sclavo; 1975; 17(3):489-99. PubMed ID: 1230049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of Vibrio cholerae O1 biotype El Tor serotype Inaba causing outbreaks of cholera in Orissa, India.
    Pal BB; Khuntia HK; Samal SK; Das SS; Chhotray GP
    Jpn J Infect Dis; 2006 Aug; 59(4):266-9. PubMed ID: 16936349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemic and endemic cholera trends over a 33-year period in Bangladesh.
    Longini IM; Yunus M; Zaman K; Siddique AK; Sack RB; Nizam A
    J Infect Dis; 2002 Jul; 186(2):246-51. PubMed ID: 12134262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A duplex vibriocidal assay to simultaneously measure bactericidal antibody titers against Vibrio cholerae O1 Inaba and Ogawa serotypes.
    Yang JS; Choi S; Kim DD; Kang SS; Yun CH; Lee K; Han SH
    J Microbiol Methods; 2009 Dec; 79(3):289-94. PubMed ID: 19796659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corresponding type-specificity of vibriocidal and agglutinating activities of Vibrio cholerae antisera: relevance to vaccine immunogenicity.
    Preston NW
    Epidemiol Infect; 1993 Jun; 110(3):489-97. PubMed ID: 8519314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of multidrug-resistant strains of Vibrio cholerae, in a cholera outbreak in Tehran-Iran, during June-September 2008.
    Ranjbar M; Rahmani E; Nooriamiri A; Gholami H; Golmohamadi A; Barati H; Rajabifar D; Barati S; Sabet MS; Zamiri A; Haghighi S; Taifehashemi P; Nojomi M
    Trop Doct; 2010 Oct; 40(4):214-6. PubMed ID: 20709810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the bacteriological diagnosis of cholera and on the characteristics of isolated strains in the Apulia epidemic during the summer of 1973].
    Rizzo G; Barbuti S; Leogrande G; Jatta E
    Ann Sclavo; 1975; 17(3):441-8. PubMed ID: 1230046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the spread of Vibrio cholerae, biotype El Tor in the environment during the period following the 1973 epidemic in Apulia].
    Leogrande G; Rizzo G; Jatta E; Barbuti S
    Ann Sclavo; 1975; 17(3):480-8. PubMed ID: 1230048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1.
    Villeneuve S; Boutonnier A; Mulard LA; Fournier JM
    Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2477-2484. PubMed ID: 10517600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of Vibrio cholerae from nightsoil during epidemics of classical and E1 Tor Cholera in East Pakistan.
    Bart KJ; Khan M; Mosley WH
    Bull World Health Organ; 1970; 43(3):421-9. PubMed ID: 5312997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholera epidemic in Solapur during July-August, 1988.
    Fule RP; Powar RM; Menon S; Basutkar SH; Saoji AM
    Indian J Med Res; 1990 Jan; 91():24-6. PubMed ID: 2345026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Seroepidemiology of cholera in Mexico].
    González-Bonilla C; Valle-Valdez JG; Núñez-León A; Moguel-Pech L; Villanueva-Zamudio A
    Rev Latinoam Microbiol; 1994; 36(4):253-6. PubMed ID: 7701134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of bactericidal antibodies directed against vibrio cholerae in an adult population in Montevideo].
    Varela G; Del'Acqua L; Hortal M
    Rev Argent Microbiol; 1995; 27(4):185-90. PubMed ID: 8850130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type-specific action of vibriocidal antibody on Vibrio cholerae.
    Pykett AH; Preston NW
    J Hyg (Lond); 1975 Dec; 75(3):399-406. PubMed ID: 1059707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and treatment with a long-acting sulphonamide of 15 carriers of Vibrio cholerae El Tor serotype Ogawa, during the 1973 cholera epidemic in Naples.
    De Lorenzo F; Buogo A; Soscia M; Schisa C
    Chemotherapy; 1977; 23(5):345-55. PubMed ID: 332466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemics of severe cholera caused by El Tor Vibrio cholerae O1 Ogawa possessing the ctxB gene of the classical biotype in Orissa, India.
    Pal BB; Khuntia HK; Samal SK; Kar SK; Patnaik B
    Int J Infect Dis; 2010 May; 14(5):e384-9. PubMed ID: 19781971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of cholera--a five year study.
    Bajaj JK; Baradker VP; Joshi SG; Damle AS; Kayararte RP; Deshmukh AB
    J Commun Dis; 2001 Dec; 33(4):282-5. PubMed ID: 12561506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.